Oriflame USA
July 22, 2026
STOCKHOLM, Sweden -- July 22, 2026
Oriflame said second-quarter euro sales fell 13% to 115.8 million euros from 132.9 million euros a year earlier, matching a 13% decline in local currencies, as Latin America grew 6% while Turkiye and Africa, Europe and CIS, and Asia all posted double-digit declines.
Adjusted EBITDA was a loss of 4.7 million euros, compared with a profit of 1.9 million euros a year earlier. The company said adjusted gross margin fell 480 basis points, citing lower volumes, inventory provisions and liquidation of excess inventory, and recorded 9.0 million euros of additional non-recurring costs excluded from adjusted EBITDA. Cash ended the quarter at 25.7 million euros, down from 32.6 million euros at the start of the period.
Management said transformation work continues under a Real Products, Real Prices and Real People agenda, including manufacturing partner transitions, pricing tests and a savings program. First-half sales were 240.9 million euros, down 14% from 278.5 million euros.